Remdesivir and molnupiravir had comparable efficacy in lung transplant recipients with mild-to-moderate COVID-19: a single center experience. - Razia D; Sindu D; Cherrier L; Grief K; Walia R; Tokman S (Frontiers in transplantation, 2024)